Clinical trial
Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi…
NCT00258427 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00258427 |
|---|---|
| Title | Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia |
| Official title | Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia MT2002-02 |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fanconi Anemia |
| Intervention type | Biological, Drug |
| Interventions | anti-thymocyte globulin, filgrastim, busulfan, cyclophosphamide, fludarabine phosphate, methylprednisolone, Hematopoietic stem cell transplantation |
| Enrollment | 14 |
| Start date | Mar 26, 2002 |
| Primary completion | Oct 10, 2020 |
| Completion | Oct 10, 2020 |
| First posted | Nov 24, 2005 |
| Last update posted | Dec 2, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: